ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity

ClinicalTrials.gov ID: NCT06979531

Public ClinicalTrials.gov record NCT06979531. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 9, 2026, 7:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity

Study identification

NCT ID
NCT06979531
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Immunovant Sciences GmbH
Industry
Enrollment
180 participants

Conditions and interventions

Interventions

  • IMVT-1402 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 74 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 29, 2025
Primary completion
Jun 30, 2028
Completion
Jun 30, 2029
Last update posted
May 7, 2026

2025 – 2029

United States locations

U.S. sites
29
U.S. states
9
U.S. cities
28
Facility City State ZIP Site status
Site Number - 1027 Covina California 91722 Recruiting
Site Number - 1007 El Cajon California 91910 Recruiting
Site Number - 1016 Menifee California 92586 Recruiting
Site Number - 1029 Thousand Oaks California 91360 Recruiting
Site Number - 1026 Upland California 91786 Recruiting
Site Number - 1014 Fort Collins Colorado 80528 Recruiting
Site Number - 1018 Hollywood Florida 33024 Recruiting
Site Number - 1021 Jupiter Florida 33458 Recruiting
Site Number - 1002 Miami Florida 33143 Recruiting
Site Number - 1004 Tamarac Florida 33321 Recruiting
Site Number - 1025 Tampa Florida 33606 Recruiting
Site Number - 1012 Chicago Illinois 60607 Recruiting
Site Number - 1033 Orland Park Illinois 60467 Recruiting
Site Number - 1030 Lake Charles Louisiana 77469 Recruiting
Site Number - 1028 New Orleans Louisiana 70112 Recruiting
Site Number - 1032 Canton New York 13675 Recruiting
Site Number - 1006 Mineola New York 11501 Recruiting
Site Number - 1013 Philadelphia Pennsylvania 19104 Recruiting
Site Number - 1015 Jackson Tennessee 38305 Recruiting
Site Number - 1000 Memphis Tennessee 38119 Recruiting
Site Number - 1001 Allen Texas 75013 Recruiting
Site Number - 1020 Amarillo Texas 79124 Recruiting
Site Number - 1022 Arlington Texas 75231 Recruiting
Site Number - 1019 Austin Texas 78745 Recruiting
Site Number - 1024 Grapevine Texas 76034 Recruiting
Site Number - 1011 Houston Texas 77030 Recruiting
Site Number - 1010 Houston Texas 77407 Recruiting
Site Number - 1023 Katy Texas 77494 Recruiting
Site Number - 1031 San Antonio Texas 78215 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 92 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06979531, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2026 · Synced May 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06979531 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →